Combination of apatinib mesylate and second-line chemotherapy for treating gastroesophageal junction adenocarcinoma

OBJECTIVE: To investigate the safety and efficacy of acitinib mesylate combined with chemotherapy in the treatment of patients with gastroesophageal junction adenocarcinoma. METHODS: A total of 119 patients with gastroesophageal junction adenocarcinoma were enrolled and randomized into an experiment...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Bin, Lu, Chaoyun, Sun, Zheng, Qu, Caiping, Chen, Ji, Hua, Zhaolai, Tong, Ruimin, Zhang, Junfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Pre-Clinical Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567765/
https://www.ncbi.nlm.nih.gov/pubmed/30991863
http://dx.doi.org/10.1177/0300060519827191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567765/
https://www.ncbi.nlm.nih.gov/pubmed/30991863
http://dx.doi.org/10.1177/0300060519827191

Ejemplares similares